The rising popularity in GLP-1 agonists for diabetes has sparked a discussion about application forms : skin-applied devices versus pills . Traditionally , GLP-1 treatments were exclusively available in oral form, but the emergence of skin applications offers a new option . Patches might benefit individuals facing issues swallowing pills , those de